Regeneus leaps on debut

The biotechnology stock lifted to 29 cents from its IPO price of 25 cents, putting the company's market capitalisation at around $53.3 million.

Regeneus (RGS) has jumped 14% on its debut as investors welcome the first non-device biotechnology float in more than two years.

The stem cell firm leapt to 28.5 cents a share at first open on the Australian Securities Exchange, compared with its initial offer price of 25 cents a share. 

This puts the market capitalisation of Regeneus at around $53.3 million.

{{content.question}}

{{ twilioFailed ? 'SMS Code Failed to Send…' : 'SMS Code Sent…' }}

Hi {{ user.FirstName }}

Looks like you've already taken a free trial

Please enter your payment details

We have sent you a code via SMS to {{user.DayPhone}}

please enter this code below to activate your membership

We cannot send you a code via SMS to {{user.DayPhone}}

If you didn't receive SMS code please

SMS code cannot be sent due to: {{ twilioStatus }}

Please select one of the options below:

Looks you are already a member. Please enter your password to proceed

Please untick this box when using a public or shared device


Verify your mobile number to unlock a FREE trial

Please sign up for full access

Updating information

Please wait ...

  • Mastercard
  • Visa
Mastercard

The email address you entered is registered with InvestSMART.

Please login or select "Don't know password"

Please untick this box when using a public or shared device


Register as a new member

(using a different email)

Related Articles